OS Therapies Statistics Share Statistics OS Therapies has 31.84M
shares outstanding. The number of shares has increased by 34.54%
in one year.
Shares Outstanding 31.84M Shares Change (YoY) 34.54% Shares Change (QoQ) 29.09% Owned by Institutions (%) n/a Shares Floating 16.96M Failed to Deliver (FTD) Shares 6,363 FTD / Avg. Volume 1.07%
Short Selling Information The latest short interest is 667.16K, so 2.09% of the outstanding
shares have been sold short.
Short Interest 667.16K Short % of Shares Out 2.09% Short % of Float 2.59% Short Ratio (days to cover) 1.1
Valuation Ratios The PE ratio is -10.06 and the forward
PE ratio is -13.72.
OS Therapies's PEG ratio is
-0.3.
PE Ratio -10.06 Forward PE -13.72 PS Ratio 0 Forward PS 5.5 PB Ratio -17.05 P/FCF Ratio -12.27 PEG Ratio -0.3
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for OS Therapies.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.2,
with a Debt / Equity ratio of -1.15.
Current Ratio 1.2 Quick Ratio 1.2 Debt / Equity -1.15 Debt / EBITDA -0.89 Debt / FCF -0.83 Interest Coverage -3320.85
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.22M Employee Count 4 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -37.57% in the
last 52 weeks. The beta is -4.14, so OS Therapies's
price volatility has been lower than the market average.
Beta -4.14 52-Week Price Change -37.57% 50-Day Moving Average 1.86 200-Day Moving Average 2.15 Relative Strength Index (RSI) 57.3 Average Volume (20 Days) 594,603
Income Statement
Revenue n/a Gross Profit -2.78K Operating Income -6.81B Net Income -8.88M EBITDA -6.83M EBIT -6.83M Earnings Per Share (EPS) -0.52
Full Income Statement Balance Sheet The company has 5.53M in cash and 6.05M in
debt, giving a net cash position of -516.47K.
Cash & Cash Equivalents 5.53M Total Debt 6.05M Net Cash -516.47K Retained Earnings -40.4M Total Assets 4.25M Working Capital 559.09K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.28M
and capital expenditures 0, giving a free cash flow of -7.28M.
Operating Cash Flow -7.28M Capital Expenditures n/a Free Cash Flow -7.28M FCF Per Share -0.35
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
